PL3788043T3 - Spiropiperydynowe allosteryczne modulatory receptorów nikotynowych acetylocholiny - Google Patents
Spiropiperydynowe allosteryczne modulatory receptorów nikotynowych acetylocholinyInfo
- Publication number
- PL3788043T3 PL3788043T3 PL19722488.4T PL19722488T PL3788043T3 PL 3788043 T3 PL3788043 T3 PL 3788043T3 PL 19722488 T PL19722488 T PL 19722488T PL 3788043 T3 PL3788043 T3 PL 3788043T3
- Authority
- PL
- Poland
- Prior art keywords
- spiropiperidine
- nicotinic acetylcholine
- allosteric modulators
- acetylcholine receptors
- receptors
- Prior art date
Links
- JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical compound C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 title 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- 230000003281 allosteric effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862665091P | 2018-05-01 | 2018-05-01 | |
| PCT/US2019/029561 WO2019212927A1 (en) | 2018-05-01 | 2019-04-29 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3788043T3 true PL3788043T3 (pl) | 2025-03-10 |
Family
ID=66429709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19722488.4T PL3788043T3 (pl) | 2018-05-01 | 2019-04-29 | Spiropiperydynowe allosteryczne modulatory receptorów nikotynowych acetylocholiny |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US11332463B2 (pl) |
| EP (1) | EP3788043B1 (pl) |
| JP (1) | JP7073533B2 (pl) |
| KR (1) | KR102587811B1 (pl) |
| CN (1) | CN112119076B (pl) |
| AR (1) | AR115065A1 (pl) |
| AU (1) | AU2019262917B2 (pl) |
| BR (1) | BR112020022088A8 (pl) |
| CA (1) | CA3098583C (pl) |
| CL (2) | CL2020002820A1 (pl) |
| CO (1) | CO2020013462A2 (pl) |
| CR (1) | CR20200509A (pl) |
| DK (1) | DK3788043T3 (pl) |
| EA (1) | EA202092608A1 (pl) |
| EC (1) | ECSP20067907A (pl) |
| ES (1) | ES2995040T3 (pl) |
| FI (1) | FI3788043T3 (pl) |
| GE (1) | GEP20227409B (pl) |
| HR (1) | HRP20241704T1 (pl) |
| HU (1) | HUE070339T2 (pl) |
| IL (1) | IL278154B2 (pl) |
| JO (1) | JOP20200272A1 (pl) |
| LT (1) | LT3788043T (pl) |
| MA (1) | MA52482B1 (pl) |
| MD (1) | MD3788043T2 (pl) |
| MX (1) | MX2020011489A (pl) |
| MY (1) | MY205690A (pl) |
| NI (1) | NI202000074A (pl) |
| PE (1) | PE20210052A1 (pl) |
| PH (1) | PH12020551779A1 (pl) |
| PL (1) | PL3788043T3 (pl) |
| PT (1) | PT3788043T (pl) |
| RS (1) | RS66290B1 (pl) |
| SG (1) | SG11202010459XA (pl) |
| SI (1) | SI3788043T1 (pl) |
| TW (1) | TWI839355B (pl) |
| UA (1) | UA126834C2 (pl) |
| WO (1) | WO2019212927A1 (pl) |
| ZA (1) | ZA202006507B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| US12331022B2 (en) | 2019-05-02 | 2025-06-17 | Merck Sharp & Dohme Llc | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
| US20220396571A1 (en) * | 2019-11-05 | 2022-12-15 | Merck Sharp & Dohme Corp. | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors |
| US20230139156A1 (en) * | 2019-12-19 | 2023-05-04 | Curia Spain, S.A.U. | Process and intermediates for the preparation of upadacitinib |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044010A1 (es) | 2003-04-11 | 2005-08-24 | Janssen Pharmaceutica Nv | Uso de derivados de 4-fenil-4- [1h-imidazol-2-il]- piperidina sustituidos como agonistas delta opioideos no peptidos selectivos, con actividad antidepresiva y ansiolitica |
| CN101815512B (zh) | 2007-10-04 | 2013-04-24 | 弗·哈夫曼-拉罗切有限公司 | 环丙基芳基酰胺衍生物和其用途 |
| KR101925971B1 (ko) | 2011-01-28 | 2018-12-06 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| WO2012103583A1 (en) | 2011-02-02 | 2012-08-09 | Bionomics Limited | Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof. |
| UA111746C2 (uk) | 2011-07-08 | 2016-06-10 | Х. Луннбек А/С | Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну |
| US8598213B2 (en) | 2011-07-08 | 2013-12-03 | H. Lundbeck A/S | Positive allosteric modulators of nicotinic acetylcholine receptor |
| WO2014006117A1 (en) | 2012-07-06 | 2014-01-09 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
| WO2014019023A1 (en) | 2012-08-01 | 2014-02-06 | Bionomics Limited | α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I |
| AU2013325615A1 (en) * | 2012-10-02 | 2015-04-09 | Sumitomo Dainippon Pharma Co., Ltd. | Imidazole derivative |
| US20150315130A1 (en) | 2012-12-10 | 2015-11-05 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
| US10208081B2 (en) * | 2014-11-26 | 2019-02-19 | Enanta Pharmaceuticals, Inc. | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof |
| EP3394068B1 (en) * | 2015-12-24 | 2024-09-11 | Genentech, Inc. | Tdo2 inhibitors |
| MD3433234T2 (ro) * | 2016-03-22 | 2022-02-28 | Merck Sharp & Dohme | Modulatori alosterici ai receptorilor nicotinici de acetilcolină |
-
2019
- 2019-04-29 PL PL19722488.4T patent/PL3788043T3/pl unknown
- 2019-04-29 BR BR112020022088A patent/BR112020022088A8/pt unknown
- 2019-04-29 KR KR1020207034124A patent/KR102587811B1/ko active Active
- 2019-04-29 US US17/049,653 patent/US11332463B2/en active Active
- 2019-04-29 WO PCT/US2019/029561 patent/WO2019212927A1/en not_active Ceased
- 2019-04-29 CN CN201980029616.2A patent/CN112119076B/zh active Active
- 2019-04-29 DK DK19722488.4T patent/DK3788043T3/da active
- 2019-04-29 MX MX2020011489A patent/MX2020011489A/es unknown
- 2019-04-29 HR HRP20241704TT patent/HRP20241704T1/hr unknown
- 2019-04-29 AR ARP190101126A patent/AR115065A1/es unknown
- 2019-04-29 GE GEAP201915499A patent/GEP20227409B/en unknown
- 2019-04-29 HU HUE19722488A patent/HUE070339T2/hu unknown
- 2019-04-29 UA UAA202007589A patent/UA126834C2/uk unknown
- 2019-04-29 PE PE2020001722A patent/PE20210052A1/es unknown
- 2019-04-29 FI FIEP19722488.4T patent/FI3788043T3/fi active
- 2019-04-29 MY MYPI2020005673A patent/MY205690A/en unknown
- 2019-04-29 CA CA3098583A patent/CA3098583C/en active Active
- 2019-04-29 EP EP19722488.4A patent/EP3788043B1/en active Active
- 2019-04-29 EA EA202092608A patent/EA202092608A1/ru unknown
- 2019-04-29 RS RS20241372A patent/RS66290B1/sr unknown
- 2019-04-29 SI SI201930865T patent/SI3788043T1/sl unknown
- 2019-04-29 MD MDE20210207T patent/MD3788043T2/ro unknown
- 2019-04-29 AU AU2019262917A patent/AU2019262917B2/en active Active
- 2019-04-29 TW TW108114867A patent/TWI839355B/zh active
- 2019-04-29 SG SG11202010459XA patent/SG11202010459XA/en unknown
- 2019-04-29 JO JOP/2020/0272A patent/JOP20200272A1/ar unknown
- 2019-04-29 ES ES19722488T patent/ES2995040T3/es active Active
- 2019-04-29 IL IL278154A patent/IL278154B2/en unknown
- 2019-04-29 PT PT197224884T patent/PT3788043T/pt unknown
- 2019-04-29 MA MA52482A patent/MA52482B1/fr unknown
- 2019-04-29 JP JP2020560807A patent/JP7073533B2/ja active Active
- 2019-04-29 CR CR20200509A patent/CR20200509A/es unknown
- 2019-04-29 LT LTEPPCT/US2019/029561T patent/LT3788043T/lt unknown
-
2020
- 2020-10-20 ZA ZA2020/06507A patent/ZA202006507B/en unknown
- 2020-10-26 CO CONC2020/0013462A patent/CO2020013462A2/es unknown
- 2020-10-26 EC ECSENADI202067907A patent/ECSP20067907A/es unknown
- 2020-10-27 NI NI202000074A patent/NI202000074A/es unknown
- 2020-10-27 PH PH12020551779A patent/PH12020551779A1/en unknown
- 2020-10-29 CL CL2020002820A patent/CL2020002820A1/es unknown
-
2021
- 2021-07-06 CL CL2021001795A patent/CL2021001795A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261807A (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| ZA201808219B (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 | |
| IL278154A (en) | Spiropiperidine compounds as allosteric modulators of nicotinic acetylcholine receptors | |
| IL264951B (en) | Positive allosteric modulators of the m1 muscarinic receptor | |
| IL272017A (en) | Positive allosteric modulators of muscarinic m2 receptor | |
| IL261058A (en) | Positive allosteric modulators of the muscarinic acetylcholine m1 receptor | |
| SG11202106378VA (en) | Modulators of hsd17b13 expression | |
| SG11202102636UA (en) | Modulators of pnpla3 expression | |
| IL275457A (en) | Spiro exo-aza inhibitors of the MENIN-MLL interaction | |
| IL274322A (en) | Spirocyclic compounds as paranoid X receptor modulators | |
| EP3544961A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINE ACETYLCHOLINE RECEPTOR M4 | |
| IL255994B (en) | Positive allosteric am.1 muscarinic receptor modulators | |
| IL278740B1 (en) | Methods for using splicing modulators | |
| IL277847A (en) | Modulators of EZH2 expression | |
| EP3534888A4 (en) | SUBSTITUTED BICYCLIC HETEROARYL-ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | |
| EP4054569A4 (en) | ALLOSTERIC SPIROPIPERIDINE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | |
| HK1259808A1 (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| EP3830083A4 (en) | ALLOSTERIC MODULATORS OF THE ?U-OPIOID RECEPTOR | |
| HK40035058A (en) | Spirocyclic compounds as farnesoid x receptor modulators | |
| HK40039898A (en) | Exo-aza spiro inhibitors of menin-mll interaction | |
| HK40039227A (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 | |
| HK40038649A (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 | |
| HK40015440A (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 | |
| HK40015439A (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |